Mark has gained marketplace-based recognition and the trust of brand-name global clients for his strategic patent guidance. He counsels both US and international biotech and pharmaceutical companies at all stages of growth — serving clients ranging from start-ups to Fortune 100 companies. Mark builds close partnerships with his clients as he helps them develop and protect their innovations. IAM Strategy 300 has included Mark on its list of the World’s Leading IP Strategists.
Mark provides biotech and pharmaceutical companies with strategic patent guidance at all stages of growth. He counsels clients on the development of their portfolios and handles initial patent applications. Mark represents domestic and international clientele with an emphasis on work in the biotech, pharmaceutical, and chemical spaces. He is truly a partner in a client’s business, helping clients develop and protect their innovations in these highly competitive and research-intensive industries.
He has helped companies at the start-up stage file their first applications, and works with Fortune 100 companies in developing their long-term strategies. Mark helps clients with mature portfolios extend the life of those portfolios to help them achieve the optimal value from their key assets.
